Browsing eNauka

Browsing by Project Takeda Development Center Americas, Inc./Takeda Pharmaceuticals International AG

Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)TypeМp-cat.
2023Facilitated subcutaneous immunoglobulin 10% for CIDP: interim results from a long-term safety and tolerability studyHadden, R; Andersen, H; Bril, Vera; Basta, Ivana Z; Rejdak, Konrad; Djordjevic, Goran D; Greco, E; Hasan, S; French, J; Yel, L;
Ay, H;
Conference Paper
Mp. category will be shown later
2024Long-term safety and tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE-CIDP 3 trialHadden, Robert DM; Andersen, Henning; Bril, Vera; Basta, Ivana; Rejdak, Konrad; Duff, Kim; Greco, Erin; Hasan, Shabbir; Anderson, Smits Colin; Ay, HakanArticle
21M21